JNJ

Johnson & Johnson: Profitability From Stability
Johnson & Johnson: Profitability From Stability
TheStreet.com
JNJ
Merck
Pfizer
Flag link:
Johnson & Johnson: My First Pick of 2010
Johnson & Johnson: My First Pick of 2010
Seeking Alpha
JNJ
Eli Lilly
Novartis
Amgen
Proctor & Gamble
Biogen Idec
Genzyme
Gilead Sciences
Teva Pharmaceuticals
King
Mylan
Pfizer
GSK
Sanofi
Abbott Laboratories
Flag link:
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Bloomberg
FDA
anemia
Amgen
Aranesp
Epogen
Procrit
JNJ
Flag link:
5-Star Stocks Poised to Pop: Johnson & Johnson
5-Star Stocks Poised to Pop: Johnson & Johnson
Motley Fool
JNJ
Flag link:
Speculative Observation: Cephalon at $62.42
Speculative Observation: Cephalon at $62.42
Seeking Alpha
Cephalon
GSK
JNJ
Flag link:
Daughter of New York Jets owner, heiress to Johnson & Johnson empire, found dead in her home
Daughter of New York Jets owner, heiress to Johnson & Johnson empire, found dead in her home
Yahoo/AP
JNJ
Casey Johnson
Flag link:
Pfizer Discontinues Cancer Drug: Biotech's Recently Missed Targets
Pfizer Discontinues Cancer Drug: Biotech's Recently Missed Targets
Seeking Alpha
Pfizer
Arena Pharmaceuticals
JNJ
Merck
Trimeris
figitumumab
Flag link:
The FDA (Still) Hates Antibiotic Makers
The FDA (Still) Hates Antibiotic Makers
Motley Fool
FDA
antibiotics
JNJ
ceftobiprole
Wyeth
Pfizer
Theravance
Flag link:
Basilea plunges on FDA rejection of J&J drug trials
Basilea plunges on FDA rejection of J&J drug trials
Marketwatch
FDA
JNJ
Basilea
ceftobiprole
Flag link:
FDA: J&J recalling contaminated Tylenol bottles
FDA: J&J recalling contaminated Tylenol bottles
Marketwatch
recalls
Tylenol
JNJ
Flag link:
Johnson & Johnson: A Compelling Investment Opportunity
Johnson & Johnson: A Compelling Investment Opportunity
Seeking Alpha
JNJ
Flag link:
Matthew Herper And Robert Langreth On The Pharmaceutical Industry: in 2010, a major drug company will break up
Matthew Herper And Robert Langreth On The Pharmaceutical Industry: in 2010, a major drug company will break up
Forbes
JNJ
Medtronic
Pfizer
Vytorin
Boehringer Ingelheim
Elan
Eli Lilly
Fate Therapeutics
Gilead Sciences
Merck
Schering Plough
Wyeth
Flag link:
Top Pharma Layoffs of 2009: Pfizer's on First, Merck's on Second, Who's on Third?
Top Pharma Layoffs of 2009: Pfizer's on First, Merck's on Second, Who's on Third?
BNET Pharma
Merck
Pfizer
drug reps
layoffs
JNJ
Flag link:
Merck and J&J Land Deals; Biogen Idec, Not So Much
Merck and J&J Land Deals; Biogen Idec, Not So Much
WSJ Online
Biogen Idec
Merck
JNJ
Facet Biotech
M&A
Flag link:
Better Buy: Johnson & Johnson or Bristol-Myers Squibb?
Better Buy: Johnson & Johnson or Bristol-Myers Squibb?
Motley Fool
JNJ
Bristol-Myers Squibb
Flag link:
Johnson & Johnson's Ethicon unit paying $785 million for sinus surgery device maker Acclarent
Johnson & Johnson's Ethicon unit paying $785 million for sinus surgery device maker Acclarent
Yahoo/AP
JNJ
M&A
Acclarent
medical devices
Flag link:
Elan: J&J unit seeks Europe schizophrenia-drug OK
Elan: J&J unit seeks Europe schizophrenia-drug OK
Marketwatch
Europe
schizophrenia
Elan
JNJ
Flag link:
Blood Thinner Battle Heats Up
Blood Thinner Battle Heats Up
Forbes
Boehringer Ingelheim
JNJ
blood thinners
Flag link:
Drugmakers tell FDA that increased education could curb misuse and abuse of painkillers
Drugmakers tell FDA that increased education could curb misuse and abuse of painkillers
Yahoo/AP
JNJ
King
Flag link:
Fed Probe Into Johnson & Johnson Reaches Zero Hour
Fed Probe Into Johnson & Johnson Reaches Zero Hour
Pharmalot
JNJ
Scios
Natrecor
Flag link: